{
  "DOI": "10.1007/s00439-012-1188-9",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-012-1188-9",
  "alternative-id": [
    "1188"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Ziegler",
      "given": "Andreas",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Koch",
      "given": "Armin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Krockenberger",
      "given": "Katja",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Großhennig",
      "given": "Anika",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        6,
        30
      ]
    ],
    "date-time": "2012-06-30T02:37:24Z",
    "timestamp": 1341023844000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        26
      ]
    ],
    "date-time": "2024-04-26T07:47:46Z",
    "timestamp": 1714117666000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        30
      ]
    ],
    "date-time": "2024-04-30T07:06:00Z",
    "timestamp": 1714460760755
  },
  "is-referenced-by-count": 146,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2012,
        7,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2012,
          10
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://www.springerlink.com/index/pdf/10.1007/s00439-012-1188-9",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1627-1638",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2012,
        7,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        7,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1191/1740774506cn130oa",
      "author": "SG Baker",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "issue": "1",
      "journal-title": "Clin Trials",
      "key": "1188_CR1",
      "unstructured": "Baker SG, Kramer BS, McIntosh M, Patterson BH, Shyr Y, Skates S (2006) Evaluating markers for the early detection of cancer: overview of study designs and methods. Clin Trials 3(1):43–56",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1067/mcp.2001.113989",
      "author": "Biomarkers Definitions Working Group",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "issue": "3",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1188_CR2",
      "unstructured": "Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95. doi: 10.1067/mcp.2001.113989",
      "volume": "69",
      "year": "2001"
    },
    {
      "DOI": "10.2217/epi.09.6",
      "author": "C Bock",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "issue": "1",
      "journal-title": "Epigenomics",
      "key": "1188_CR3",
      "unstructured": "Bock C (2009) Epigenetic biomarker development. Epigenomics 1(1):99–110. doi: 10.2217/epi.09.6",
      "volume": "1",
      "year": "2009"
    },
    {
      "DOI": "10.1093/fampra/cmh103",
      "author": "PM Bossuyt",
      "doi-asserted-by": "crossref",
      "first-page": "4",
      "issue": "1",
      "journal-title": "Fam Pract",
      "key": "1188_CR4",
      "unstructured": "Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2004) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract 21(1):4–10",
      "volume": "21",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s11894-011-0220-x",
      "author": "AM Buchner",
      "doi-asserted-by": "crossref",
      "first-page": "465",
      "issue": "5",
      "journal-title": "Curr Gastroenterol Rep",
      "key": "1188_CR5",
      "unstructured": "Buchner AM, Blonski W, Lichtenstein GR (2011) Update on the management of Crohn’s disease. Curr Gastroenterol Rep 13(5):465–474. doi: 10.1007/s11894-011-0220-x",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1586/erm.10.120",
      "author": "M Buyse",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "issue": "2",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "1188_CR6",
      "unstructured": "Buyse M, Michiels S, Sargent DJ, Grothey A, Matheson A, de Gramont A (2011) Integrating biomarkers in clinical trials. Expert Rev Mol Diagn 11(2):171–182. doi: 10.1586/erm.10.120",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1517/13543784.2010.510513",
      "author": "M Cottone",
      "doi-asserted-by": "crossref",
      "first-page": "1147",
      "issue": "10",
      "journal-title": "Expert Opin Investig Drugs",
      "key": "1188_CR7",
      "unstructured": "Cottone M, Orlando A, Renna S (2010) Investigational agents for Crohn’s disease. Expert Opin Investig Drugs 19(10):1147–1159. doi: 10.1517/13543784.2010.510513",
      "volume": "19",
      "year": "2010"
    },
    {
      "author": "K Egerer",
      "first-page": "159",
      "issue": "10",
      "journal-title": "Dtsch Arztebl Int",
      "key": "1188_CR8",
      "unstructured": "Egerer K, Feist E, Burmester GR (2009) The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens. Dtsch Arztebl Int 106(10):159–163. doi: 10.3238/arztebl.2009.0159",
      "volume": "106",
      "year": "2009"
    },
    {
      "author": "S Rouby El",
      "first-page": "15",
      "issue": "1",
      "journal-title": "J Heart Valve Dis",
      "key": "1188_CR9",
      "unstructured": "El Rouby S, Mestres CA, LaDuca FM, Zucker ML (2004) Racial and ethnic differences in warfarin response. J Heart Valve Dis 13(1):15–21",
      "volume": "13",
      "year": "2004"
    },
    {
      "key": "1188_CR10",
      "unstructured": "European Medicines Agency (1998a) ICH Topic E5 (R1): ethnic factors in the acceptability of foreign clinical data. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002842.pdf . Last accessed Feb 16, 2012"
    },
    {
      "key": "1188_CR11",
      "unstructured": "European Medicines Agency (1998b) ICH Topic E8: general considerations for clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002877.pdf . Last accessed Feb 13, 2012"
    },
    {
      "key": "1188_CR12",
      "unstructured": "European Medicines Agency (2009) Guideline on clinical evaluation of diagnostic agents. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003580.pdf . Last accessed Feb 17, 2012"
    },
    {
      "key": "1188_CR13",
      "unstructured": "European Medicines Agency (2012) Qualification of novel methodologies for drug development: guidance to applicants. http://www.emea.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004201.pdf . Last accessed May 13, 2012"
    },
    {
      "DOI": "10.1371/journal.pone.0007753",
      "author": "PS Fontela",
      "doi-asserted-by": "crossref",
      "first-page": "e7753",
      "issue": "11",
      "journal-title": "PLoS One",
      "key": "1188_CR14",
      "unstructured": "Fontela PS, Pant Pai N, Schiller I, Dendukuri N, Ramsay A, Pai M (2009) Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PLoS One 4(11):e7753. doi: 10.1371/journal.pone.0007753",
      "volume": "4",
      "year": "2009"
    },
    {
      "key": "1188_CR15",
      "unstructured": "Food and Drug Administration (2011) In vitro companion diagnostic devices. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf . Last accessed Feb 13, 2012"
    },
    {
      "DOI": "10.1371/journal.pmed.1001117",
      "author": "V Gallo",
      "doi-asserted-by": "crossref",
      "first-page": "e1001117",
      "issue": "10",
      "journal-title": "PLoS Med",
      "key": "1188_CR16",
      "unstructured": "Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P (2011) strengthening the reporting of observational studies in epidemiology—molecular epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med 8(10):e1001117. doi: 10.1371/journal.pmed.1001117",
      "volume": "8",
      "year": "2011"
    },
    {
      "DOI": "10.1007/978-0-387-73003-5_106",
      "author": "T Hicks",
      "doi-asserted-by": "crossref",
      "first-page": "573",
      "key": "1188_CR17",
      "unstructured": "Hicks T, Coquoz R (2009) Forensic DNA evidence. In: Li SZ (ed) Encyclopedia of biometrics. Springer, New York, pp 573–579",
      "volume-title": "Encyclopedia of biometrics",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.cld.2011.05.009",
      "author": "JA Holmes",
      "doi-asserted-by": "crossref",
      "first-page": "497",
      "issue": "3",
      "journal-title": "Clin Liver Dis",
      "key": "1188_CR18",
      "unstructured": "Holmes JA, Desmond PV, Thompson AJ (2011) Redefining baseline demographics: the role of genetic testing in hepatitis C virus infection. Clin Liver Dis 15(3):497–513. doi: 10.1016/j.cld.2011.05.009",
      "volume": "15",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/ddn250",
      "doi-asserted-by": "crossref",
      "key": "1188_CR19",
      "unstructured": "Janssens AC, van Duijn CM (2008) Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet 17(R2):R166–R173. doi: 10.1093/hmg/ddn250"
    },
    {
      "DOI": "10.1056/NEJMoa0804385",
      "author": "CS Karapetis",
      "doi-asserted-by": "crossref",
      "first-page": "1757",
      "issue": "17",
      "journal-title": "N Engl J Med",
      "key": "1188_CR20",
      "unstructured": "Karapetis CS, Khambata-Ford S, Jonker DJ, O’Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359(17):1757–1765. doi: 10.1056/NEJMoa0804385",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2010.31.8923",
      "author": "VL Keedy",
      "doi-asserted-by": "crossref",
      "first-page": "2121",
      "issue": "15",
      "journal-title": "J Clin Oncol",
      "key": "1188_CR21",
      "unstructured": "Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G (2011) American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol 29(15):2121–2127. doi: 10.1200/JCO.2010.31.8923",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-011-1683-z",
      "doi-asserted-by": "crossref",
      "key": "1188_CR22",
      "unstructured": "Krijgsman O, Roepman P, Zwart W, Carroll JS, Tian S, de Snoo FA, Bender RA, Bernards R, Glas AM (2012) A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. Breast Cancer Res Treat 133(1):37–47. doi: 10.1007/s10549-011-1683-z"
    },
    {
      "author": "W Kroll",
      "first-page": "1",
      "key": "1188_CR23",
      "unstructured": "Kroll W (2008) Biomarkers—predictors, surrogate parameters—a concept definition. In: Schmitz G, Endres S, Götte D (eds) Biomarker. Schattauer, Stuttgart, pp 1–14",
      "volume-title": "Biomarker",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s00439-012-1194-y",
      "doi-asserted-by": "crossref",
      "key": "1188_CR100",
      "unstructured": "Kruppa J, Ziegler A, König IR (2012) Risk estimation and risk prediction using machine learning methods. Hum Genet (in press)"
    },
    {
      "DOI": "10.1002/sim.2151",
      "author": "JM Lachin",
      "doi-asserted-by": "crossref",
      "first-page": "2747",
      "issue": "18",
      "journal-title": "Stat Med",
      "key": "1188_CR24",
      "unstructured": "Lachin JM (2005) A review of methods for futility stopping based on conditional power. Stat Med 24(18):2747–2764. doi: 10.1002/sim.2151",
      "volume": "24",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMoa0801936",
      "author": "E Link",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "issue": "8",
      "journal-title": "N Engl J Med",
      "key": "1188_CR25",
      "unstructured": "Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R (2008) SLCO1B1 variants and statin-induced myopathy—a genomewide study. N Engl J Med 359(8):789–799. doi: 10.1056/NEJMoa0801936",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1007/978-1-60327-811-9_9",
      "author": "F Linkov",
      "doi-asserted-by": "crossref",
      "first-page": "129",
      "journal-title": "Methods Mol Biol",
      "key": "1188_CR26",
      "unstructured": "Linkov F, Yurkovetsky Z, Lokshin A (2009) Hormones as biomarkers: practical guide to utilizing luminex technologies for biomarker research. Methods Mol Biol 520:129–141. doi: 10.1007/978-1-60327-811-9_9",
      "volume": "520",
      "year": "2009"
    },
    {
      "DOI": "10.1080/10543400902802458",
      "author": "SJ Mandrekar",
      "doi-asserted-by": "crossref",
      "first-page": "530",
      "issue": "3",
      "journal-title": "J Biopharm Stat",
      "key": "1188_CR27",
      "unstructured": "Mandrekar SJ, Sargent DJ (2009a) Clinical trial designs for predictive biomarker validation: one size does not fit all. J Biopharm Stat 19(3):530–542. doi: 10.1080/10543400902802458",
      "volume": "19",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2009.22.3701",
      "author": "SJ Mandrekar",
      "doi-asserted-by": "crossref",
      "first-page": "4027",
      "issue": "24",
      "journal-title": "J Clin Oncol",
      "key": "1188_CR28",
      "unstructured": "Mandrekar SJ, Sargent DJ (2009b) Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. J Clin Oncol 27(24):4027–4034. doi: 10.1200/JCO.2009.22.3701",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMra0905980",
      "author": "TA Manolio",
      "doi-asserted-by": "crossref",
      "first-page": "166",
      "issue": "2",
      "journal-title": "N Engl J Med",
      "key": "1188_CR29",
      "unstructured": "Manolio TA (2010) Genomewide association studies and assessment of the risk of disease. N Engl J Med 363(2):166–176. doi: 10.1056/NEJMra0905980",
      "volume": "363",
      "year": "2010"
    },
    {
      "DOI": "10.1002/pros.21444",
      "author": "P Massoner",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "issue": "4",
      "journal-title": "Prostate",
      "key": "1188_CR30",
      "unstructured": "Massoner P, Lüking A, Göhler H, Hopfner A, Kowald A, Kugler KG, Amersdorfer P, Horninger W, Bartsch G, Schulz-Knappe P, Klocker H (2012) Serum-autoantibodies for discovery of prostate cancer specific biomarkers. Prostate 72(4):427–436. doi: 10.1002/pros.21444",
      "volume": "72",
      "year": "2012"
    },
    {
      "DOI": "10.1093/jnci/dji237",
      "author": "LM McShane",
      "doi-asserted-by": "crossref",
      "first-page": "1180",
      "issue": "16",
      "journal-title": "J Natl Cancer Inst",
      "key": "1188_CR31",
      "unstructured": "McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97(16):1180–1184. doi: 10.1093/jnci/dji237",
      "volume": "97",
      "year": "2005"
    },
    {
      "DOI": "10.1136/bmj.b2535",
      "author": "D Moher",
      "doi-asserted-by": "crossref",
      "first-page": "b2535",
      "journal-title": "BMJ",
      "key": "1188_CR32",
      "unstructured": "Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535",
      "volume": "339",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa0810699",
      "author": "TS Mok",
      "doi-asserted-by": "crossref",
      "first-page": "947",
      "issue": "10",
      "journal-title": "N Engl J Med",
      "key": "1188_CR33",
      "unstructured": "Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M (2009) Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361(10):947–957. doi: 10.1056/NEJMoa0810699",
      "volume": "361",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pone.0011419",
      "author": "LA Parker",
      "doi-asserted-by": "crossref",
      "first-page": "e11419",
      "issue": "7",
      "journal-title": "PLoS One",
      "key": "1188_CR34",
      "unstructured": "Parker LA, Gomez Saez N, Lumbreras B, Porta M, Hernandez-Aguado I (2010) Methodological deficits in diagnostic research using ‘-omics’ technologies: evaluation of the QUADOMICS tool and quality of recently published studies. PLoS One 5(7):e11419. doi: 10.1371/journal.pone.0011419",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1093/oso/9780198509844.001.0001",
      "author": "MS Pepe",
      "doi-asserted-by": "crossref",
      "key": "1188_CR35",
      "unstructured": "Pepe MS (2003) The statistical evaluation of medical tests for classification and prediction. Oxford University Press, New York",
      "volume-title": "The statistical evaluation of medical tests for classification and prediction",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/93.14.1054",
      "author": "MS Pepe",
      "doi-asserted-by": "crossref",
      "first-page": "1054",
      "issue": "14",
      "journal-title": "J Natl Cancer Inst",
      "key": "1188_CR36",
      "unstructured": "Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93(14):1054–1061",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.5694/j.1326-5377.2006.tb00557.x",
      "author": "AC Plint",
      "doi-asserted-by": "crossref",
      "first-page": "263",
      "issue": "5",
      "journal-title": "Med J Aust",
      "key": "1188_CR37",
      "unstructured": "Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I (2006) Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 185(5):263–267",
      "volume": "185",
      "year": "2006"
    },
    {
      "DOI": "10.2307/2533262",
      "author": "MA Proschan",
      "doi-asserted-by": "crossref",
      "first-page": "1315",
      "issue": "4",
      "journal-title": "Biometrics",
      "key": "1188_CR38",
      "unstructured": "Proschan MA, Hunsberger SA (1995) Designed extension of studies based on conditional power. Biometrics 51(4):1315–1324",
      "volume": "51",
      "year": "1995"
    },
    {
      "DOI": "10.1038/sj.bjc.6604999",
      "author": "RD Riley",
      "doi-asserted-by": "crossref",
      "first-page": "1219",
      "issue": "8",
      "journal-title": "Br J Cancer",
      "key": "1188_CR39",
      "unstructured": "Riley RD, Sauerbrei W, Altman DG (2009) Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer 100(8):1219–1229. doi: 10.1038/sj.bjc.6604999",
      "volume": "100",
      "year": "2009"
    },
    {
      "DOI": "10.1517/17425255.2011.585969",
      "author": "K Sai",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "issue": "8",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "1188_CR40",
      "unstructured": "Sai K, Saito Y (2011) Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs. Expert Opin Drug Metab Toxicol 7(8):967–988. doi: 10.1517/17425255.2011.585969",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.1200/JCO.2005.01.112",
      "author": "DJ Sargent",
      "doi-asserted-by": "crossref",
      "first-page": "2020",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "1188_CR41",
      "unstructured": "Sargent DJ, Conley BA, Allegra C, Collette L (2005) Clinical trial designs for predictive marker validation in cancer treatment trials. J Clin Oncol 23(9):2020–2027. doi: 10.1200/JCO.2005.01.112",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1002/bimj.200510234",
      "author": "H Schäfer",
      "doi-asserted-by": "crossref",
      "first-page": "507",
      "issue": "4",
      "journal-title": "Biom J",
      "key": "1188_CR42",
      "unstructured": "Schäfer H, Timmesfeld N, Müller HH (2006) An overview of statistical approaches for adaptive designs and design modifications. Biom J 48(4):507–520",
      "volume": "48",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nbt.1634",
      "author": "FD Sistare",
      "doi-asserted-by": "crossref",
      "first-page": "446",
      "issue": "5",
      "journal-title": "Nat Biotechnol",
      "key": "1188_CR43",
      "unstructured": "Sistare FD, Dieterle F, Troth S, Holder DJ, Gerhold D, Andrews-Cleavenger D, Baer W, Betton G, Bounous D, Carl K, Collins N, Goering P, Goodsaid F, Gu YZ, Guilpin V, Harpur E, Hassan A, Jacobson-Kram D, Kasper P, Laurie D, Lima BS, Maciulaitis R, Mattes W, Maurer G, Obert LA, Ozer J, Papaluca-Amati M, Phillips JA, Pinches M, Schipper MJ, Thompson KL, Vamvakas S, Vidal JM, Vonderscher J, Walker E, Webb C, Yu Y (2010) Towards consensus practices to qualify safety biomarkers for use in early drug development. Nat Biotechnol 28(5):446–454. doi: 10.1038/nbt.1634",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1586/erm.09.32",
      "author": "EA Slodkowska",
      "doi-asserted-by": "crossref",
      "first-page": "417",
      "issue": "5",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "1188_CR44",
      "unstructured": "Slodkowska EA, Ross JS (2009) MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn 9(5):417–422. doi: 10.1586/erm.09.32",
      "volume": "9",
      "year": "2009"
    },
    {
      "author": "DL Thomas",
      "journal-title": "Clin Infect Dis",
      "key": "1188_CR45",
      "unstructured": "Thomas DL, Bartlett JG, Peters MG, Shermann KE, Sulkowski MS, Pham PA (2012) Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis. doi: 10.1093/cid/cir882",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrd2251",
      "author": "MR Trusheim",
      "doi-asserted-by": "crossref",
      "first-page": "287",
      "issue": "4",
      "journal-title": "Nat Rev Drug Discov",
      "key": "1188_CR46",
      "unstructured": "Trusheim MR, Berndt ER, Douglas FL (2007) Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 6(4):287–293. doi: 10.1038/nrd2251",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1093/eurheartj/ehr239",
      "author": "JJ Verschuren",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "issue": "2",
      "journal-title": "Eur Heart J",
      "key": "1188_CR47",
      "unstructured": "Verschuren JJ, Trompet S, Wessels JA, Guchelaar HJ, de Maat MP, Simoons ML, Jukema JW (2012) A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? Eur Heart J 33(2):165–175. doi: 10.1093/eurheartj/ehr239",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1177/1740774510375455",
      "author": "SJ Wang",
      "doi-asserted-by": "crossref",
      "first-page": "525",
      "issue": "5",
      "journal-title": "Clin Trials",
      "key": "1188_CR48",
      "unstructured": "Wang SJ, O’Neill RT, Hung HJ (2010) Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials. Clin Trials 7(5):525–536. doi: 10.1177/1740774510375455",
      "volume": "7",
      "year": "2010"
    },
    {
      "author": "EA Wayner",
      "journal-title": "Prostate",
      "key": "1188_CR49",
      "unstructured": "Wayner EA, Quek SI, Ahmad R, Ho ME, Loprieno MA, Zhou Y, Ellis WJ, True LD, Liu AY (2011) Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine. Prostate. doi: 10.1002/pros.21508",
      "year": "2011"
    },
    {
      "author": "X-H Zhou",
      "key": "1188_CR50",
      "unstructured": "Zhou X-H, Obuchowski NA, McClish DK (2001) Statistical methods in diagnostic medicine. Wiley, New York",
      "volume-title": "Statistical methods in diagnostic medicine",
      "year": "2001"
    }
  ],
  "reference-count": 51,
  "references-count": 51,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-012-1188-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Personalized medicine using DNA biomarkers: a review"
  ],
  "type": "journal-article",
  "volume": "131"
}